tiprankstipranks
Sun Pharma Advanced Research Co. Ltd. (IN:SPARC)
:SPARC
India Market
SPARC
Sun Pharma Advanced Research Co. Ltd.
RESEARCH TOOLSreports
Want to see IN:SPARC full AI Analyst Report?

Sun Pharma Advanced Research Co. Ltd. (SPARC) Ratios

7 Followers

Sun Pharma Advanced Research Co. Ltd. Ratios

IN:SPARC's free cash flow for Q2 2026 was ₹-0.80. For the 2026 fiscal year, IN:SPARC's free cash flow was decreased by ₹ and operating cash flow was ₹-8.69. See a summary of the company’s cash flow.
Ratios
TTM
Mar 26Mar 25Mar 24Mar 23
Liquidity Ratios
Current Ratio
 2.47 2.47 0.07 1.02 2.54
Quick Ratio
 2.47 2.47 0.07 1.02 2.57
Cash Ratio
 <0.01 <0.01 <0.01 0.02 <0.01
Solvency Ratio
 1.88 1.88 -0.60 -0.96 -0.66
Operating Cash Flow Ratio
 -0.15 -0.36 -0.96 -1.62 -0.39
Short-Term Operating Cash Flow Coverage
 -0.21 -0.49 -2.28 -9.13 -1.36K
Net Current Asset Value
₹ 10.30B₹ 10.30B₹ -5.26B₹ -1.20B₹ 1.38B
Leverage Ratios
Debt-to-Assets Ratio
 0.26 0.26 0.80 0.12 0.02
Debt-to-Equity Ratio
 0.42 0.42 -1.24 0.49 0.03
Debt-to-Capital Ratio
 0.29 0.29 5.17 0.33 0.03
Long-Term Debt-to-Capital Ratio
 0.00 0.00 -0.86 0.00 0.00
Financial Leverage Ratio
 1.62 1.62 -1.55 4.10 1.62
Debt Service Coverage Ratio
 2.70 2.70 -1.93 -7.67 -26.44
Interest Coverage Ratio
 46.54 46.54 -30.75 -243.49 -29.29
Debt to Market Cap
 0.08 0.15 0.05 <0.01 <0.01
Interest Debt Per Share
 18.28 18.29 8.56 1.94 0.82
Net Debt to EBITDA
 0.35 0.35 -0.83 -0.15 -0.07
Profitability Margins
Gross Profit Margin
94.71%91.92%67.79%-163.91%34.39%
EBIT Margin
84.36%84.53%-467.51%-510.47%-90.02%
EBITDA Margin
84.91%85.08%-450.24%-493.94%-85.09%
Operating Profit Margin
84.53%84.53%-387.32%-544.71%-93.66%
Pretax Profit Margin
82.64%82.64%-477.61%-512.05%-93.22%
Net Profit Margin
82.65%82.65%-477.23%-512.56%-93.22%
Continuous Operations Profit Margin
82.65%82.65%-477.23%-512.56%-93.22%
Net Income Per EBT
100.01%100.01%99.92%100.10%100.00%
EBT Per EBIT
97.76%97.76%123.31%94.00%99.52%
Return on Assets (ROA)
71.55%71.55%-102.08%-75.18%-26.81%
Return on Equity (ROE)
1108.87%116.01%157.88%-307.91%-43.41%
Return on Capital Employed (ROCE)
112.12%112.12%718.11%-164.61%-34.34%
Return on Invested Capital (ROIC)
80.46%80.40%-225.33%-136.95%-34.18%
Return on Tangible Assets
73.98%73.98%-121.51%-81.98%-27.66%
Earnings Yield
22.81%41.66%-7.21%-3.15%-4.36%
Efficiency Ratios
Receivables Turnover
 222.65 222.65 4.47 4.11 6.38
Payables Turnover
 1.02 1.56 0.20 1.40 1.16
Inventory Turnover
 0.00 0.00 0.00 0.00 -41.17
Fixed Asset Turnover
 21.93 21.93 0.72 0.70 2.23
Asset Turnover
 0.87 0.87 0.21 0.15 0.29
Working Capital Turnover Ratio
 5.96 4.94 -0.42 0.54 2.72
Cash Conversion Cycle
 -355.39 -231.89 -1.72K -171.59 -267.05
Days of Sales Outstanding
 1.64 1.64 81.68 88.91 57.20
Days of Inventory Outstanding
 0.00 0.00 0.00 0.00 -8.87
Days of Payables Outstanding
 357.03 233.53 1.80K 260.50 315.38
Operating Cycle
 1.64 1.64 81.68 88.91 48.33
Cash Flow Ratios
Operating Cash Flow Per Share
 -3.57 -8.41 -11.10 -13.22 -2.43
Free Cash Flow Per Share
 -4.28 -9.15 -11.42 -14.04 -2.97
CapEx Per Share
 0.71 0.73 0.32 0.82 0.54
Free Cash Flow to Operating Cash Flow
 1.20 1.09 1.03 1.06 1.22
Dividend Paid and CapEx Coverage Ratio
 -5.01 -11.45 -34.84 -16.19 -4.49
Capital Expenditure Coverage Ratio
 -5.01 -11.45 -34.84 -16.19 -4.49
Operating Cash Flow Coverage Ratio
 -0.21 -0.49 -1.34 -7.02 -4.41
Operating Cash Flow to Sales Ratio
 -0.06 -0.15 -5.02 -5.68 -0.29
Free Cash Flow Yield
-2.04%-7.96%-7.80%-3.70%-1.66%
Valuation Ratios
Price-to-Earnings (P/E) Ratio
 4.38 2.40 -13.87 -31.79 -22.94
Price-to-Sales (P/S) Ratio
 3.62 1.98 66.17 162.94 21.38
Price-to-Book (P/B) Ratio
 5.09 2.78 -21.89 97.88 9.96
Price-to-Free Cash Flow (P/FCF) Ratio
 -48.97 -12.56 -12.81 -27.01 -60.42
Price-to-Operating Cash Flow Ratio
 -58.76 -13.66 -13.18 -28.68 -73.87
Price-to-Earnings Growth (PEG) Ratio
 <0.01 >-0.01 1.20 -0.60 -19.70
Price-to-Fair Value
 5.09 2.78 -21.89 97.88 9.96
Enterprise Value Multiple
 4.62 2.68 -15.52 -33.14 -25.21
Enterprise Value
 73.66B 42.87B 50.16B 123.65B 51.21B
EV to EBITDA
 4.62 2.68 -15.52 -33.14 -25.21
EV to Sales
 3.92 2.28 69.89 163.68 21.45
EV to Free Cash Flow
 -52.99 -14.44 -13.53 -27.13 -60.60
EV to Operating Cash Flow
 -63.57 -15.70 -13.92 -28.81 -74.09
Tangible Book Value Per Share
 39.05 39.06 -8.34 2.56 17.12
Shareholders’ Equity Per Share
 41.25 41.25 -6.68 3.87 18.01
Tax and Other Ratios
Effective Tax Rate
 >-0.01 >-0.01 <0.01 >-0.01 0.00
Revenue Per Share
 57.90 57.90 2.21 2.33 8.39
Net Income Per Share
 47.86 47.86 -10.55 -11.93 -7.82
Tax Burden
 1.00 1.00 1.00 1.00 1.00
Interest Burden
 0.98 0.98 1.02 1.00 1.04
Research & Development to Revenue
 0.01 0.01 1.13 6.35 1.90
SG&A to Revenue
 0.05 0.06 3.42 2.02 0.55
Stock-Based Compensation to Revenue
 0.00 0.00 0.00 0.00 0.00
Income Quality
 0.36 -0.18 1.05 1.11 0.31
Currency in INR